NCT02388373View on ClinicalTrials.gov

A Guideline Approach to Therapy Step-down Utilising Flutiform Change and Step-down

PHASE4CompletedINTERVENTIONAL
Enrollment

225

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

February 29, 2016

Study Completion Date

March 31, 2016

Conditions
Asthma
Interventions
DRUG

Fluticasone 250/formoterol 10

DRUG

Fluticasone 250/salmeterol 25

DRUG

Fluticasone 125/formoterol 5

Trial Locations (1)

CB24 3BA

Research in Real Life Ltd, Cambridge

Sponsors
All Listed Sponsors
collaborator

Napp Pharmaceuticals Limited

INDUSTRY

lead

Research in Real-Life Ltd

NETWORK